Increased levels of IL-32γ in synovial biopsies and IL-32 in synovial fibroblasts have been demonstrated in RA patients compared to those with osteoarthritis, suggesting that the modulation of IL-32 isoforms could be a strategy for controlling inflammation [40,41]. The gene discussed is IL32; the disease is osteoarthritis.